To identify whether these markers were unique to infiltrating myeloid cells compared to all other cells in the tumor microenvironment, we compared the CD11b+ cells from the CD11b-positive bead-enriched fraction to CD11b- cells from the CD11b-negative flow-through (n = 11). This evidence concerns the gene ITGAM and neoplasm.